<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2009</study_start_year><condition>Colorectal cancer</condition><condition>Colorectal Neoplasms</condition><condition>Advanced Colorectal Cancer</condition><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Advanced Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2150603</full_dataset_link><location>South Korea</location><study_start_month>12</study_start_month><keyword>Gemcitabine</keyword><keyword>S-1</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.</name><description>To assess the efficacy and safety of salvage tratment with Gemcitabine and S-1 Combination in metastatic colorectal cancer</description><dates><creation>2009-12-15</creation></dates><accession>2150603</accession><cross_references><ClinicalTrials___gov>NCT01929421</ClinicalTrials___gov></cross_references></HashMap>